Market Share of Mexico Insulin Drugs And Delivery Devices Industry
The Mexico Insulin Drugs and Delivery Devices Market is moderately consolidated, with few significant and generic players. Mergers and acquisitions between the players recently have helped the companies strengthen their market presence. Eli Lilly and Boehringer Ingelheim have an alliance in developing and commercializing Basaglar (Insulin Glargine). Additionally, the players in the recent past helped the companies strengthen their market presence; for example, Novo Nordisk collaborated with Ypsomed to provide better insulin therapy solutions.
Mexico Insulin Drugs And Delivery Devices Market Leaders
-
Novo Nordisk
-
Sanofi
-
Eli Lilly
-
Medtronic
-
Becton Dickinson
*Disclaimer: Major Players sorted in no particular order
